Display options
Cite
de Matos CT, Berg L, Michaëlsson J, et al. Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion. Immunology. 2007;122(2):291-301doi: 10.1111/j.1365-2567.2007.02638.x.
de Matos, C. T., Berg, L., Michaëlsson, J., Felländer-Tsai, L., Kärre, K., & Söderström, K. (2007). Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion. Immunology, 122(2), 291-301. https://doi.org/10.1111/j.1365-2567.2007.02638.x
de Matos, Cristina Teixeira, et al. "Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion." Immunology vol. 122,2 (2007): 291-301. doi: https://doi.org/10.1111/j.1365-2567.2007.02638.x
de Matos CT, Berg L, Michaëlsson J, Felländer-Tsai L, Kärre K, Söderström K. Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion. Immunology. 2007 Oct;122(2):291-301. doi: 10.1111/j.1365-2567.2007.02638.x. Epub 2007 May 22. PMID: 17521371; PMCID: PMC2266001.
Copy Download .nbib Format: NLM
Share it on

Immunology. 2007 Oct;122(2):291-301. doi: 10.1111/j.1365-2567.2007.02638.x. Epub 2007 May 22.

Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion.

Immunology

Cristina Teixeira de Matos, Louise Berg, Jakob Michaëlsson, Li Felländer-Tsai, Klas Kärre, Kalle Söderström

Affiliations

  1. Department of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden. [email protected]

PMID: 17521371 PMCID: PMC2266001 DOI: 10.1111/j.1365-2567.2007.02638.x

Abstract

Natural killer (NK) cells are activated early during inflammatory events and contribute to the shaping of the ensuing adaptive immune response. To further understand the role for NK cells in inflammation, we investigated the phenotype and function of synovial fluid (SF) NK cells from patients with chronic joint inflammation, as well as from patients with transient inflammation of the knee following trauma. We confirm that synovial NK cells are similar to the well-characterized CD56(bright) peripheral blood (PB) NK-cell subset present in healthy individuals. However, compared to this PB subset the synovial NK cells express a higher degree of activation markers including CD69 and NKp44, the latter being up-regulated also on CD56(bright) NK cells in the PB of patients. Activated synovial NK cells produced interferon-gamma and tumour necrosis factor, and the production was further up-regulated by antibody masking of CD94/NKG2A, and down-regulated by target cells expressing human leucocyte antigen-E in complex with peptides known to engage CD94/NKG2A. We conclude that synovial NK cells have an activated phenotype and that CD94/NKG2A is a key regulator of synovial NK-cell cytokine synthesis.

References

  1. Nature. 1998 Feb 19;391(6669):795-9 - PubMed
  2. Annu Rev Immunol. 1996;14:397-440 - PubMed
  3. Cell Immunol. 1999 May 1;193(2):226-35 - PubMed
  4. J Immunol. 2004 Nov 15;173(10):6418-26 - PubMed
  5. Proc Natl Acad Sci U S A. 2004 Nov 23;101(47):16606-11 - PubMed
  6. Arthritis Res Ther. 2005;7(4):R784-95 - PubMed
  7. Eur Respir J. 2005 Jul;26(1):77-85 - PubMed
  8. J Immunol. 2005 Nov 15;175(10):6852-60 - PubMed
  9. Curr Opin Rheumatol. 2000 May;12(3):186-94 - PubMed
  10. Annu Rev Immunol. 2001;19:197-223 - PubMed
  11. Blood. 2001 May 15;97(10):3146-51 - PubMed
  12. Eur J Immunol. 2001 Oct;31(10):3121-7 - PubMed
  13. Trends Immunol. 2001 Nov;22(11):633-40 - PubMed
  14. Arthritis Rheum. 2002 Feb;46(2):298-308 - PubMed
  15. Arthritis Rheum. 2002 Jul;46(7):1763-72 - PubMed
  16. J Exp Med. 2002 Dec 2;196(11):1403-14 - PubMed
  17. Blood. 2003 Apr 15;101(8):3052-7 - PubMed
  18. Rheumatology (Oxford). 2003 Jul;42(7):870-8 - PubMed
  19. Eur J Immunol. 2003 Sep;33(9):2410-8 - PubMed
  20. J Immunol. 2004 Feb 1;172(3):1455-62 - PubMed
  21. Am J Med Sci. 2004 Apr;327(4):196-201 - PubMed
  22. Eur J Immunol. 2004 Jun;34(6):1715-22 - PubMed
  23. Rheum Dis Clin North Am. 2004 May;30(2):393-403, viii - PubMed
  24. J Immunol. 1989 Nov 15;143(10):3183-91 - PubMed
  25. J Exp Med. 1990 May 1;171(5):1527-33 - PubMed
  26. Scand J Immunol. 1990 Jun;31(6):283-8 - PubMed
  27. Arthritis Rheum. 1991 Apr;34(4):423-31 - PubMed
  28. Immunity. 1998 Jun;8(6):693-701 - PubMed

Substances

MeSH terms

Publication Types